Clinical trials of a simple and accurate blood test to detect early-stage ovarian cancer – key to boosting survival rates – ...
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...
AVEO Oncology, an LG Chem company ("AVEO"), is a biopharmaceutical company that is trying to provide differentiated solutions to improve cancer patients lives, presented two posters during the 2025 ...
Million Private Placement Financing from Existing Investors$2.0 Million Funding Advance from the Cancer Prevention and Research Institute of ...
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...
NT219, a novel agent designed to overcome tumor resistance to drug therapy, will be evaluated in combination with the standard-of-care head and ...
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their ...
Stanford scientists have identified 380 key genetic variants that significantly influence cancer development, filtering ...